Original Literature | Model OverView |
---|---|
Publication
Title
Signalling pathways mediating type I interferon gene expression.
Affiliation
Department of Respiratory Medicine, National Heart and Lung Institute, MRCCentre in Allergic Mechanisms of Asthma, St Marys Campus, Norfolk Place, LondonW2 1PG, UK. michael.edwards@imperial.ac.uk
Abstract
Type I interferon-alpha/beta play an essential role in immunity to viruses.While interferon-beta has been used as a model of a complex promoter, many ofthe signalling pathways leading to interferon-beta gene expression remaincontroversial. Recent milestones include the discovery of Toll-like receptorsand RNA helicases that signal via a novel kinase complex composed of I kappa Bkinase-iota/epsilon or TANK binding kinase-1. This review provides a timelysummary of this rapidly expanding field, focusing specifically on the variousviral RNA binding molecules and their associated signalling pathways.
PMID
17904888
|
Entity
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m42
10
infinite
0
TRANSPATH | MO000000058 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
JNK2{active}
--
MO000016903
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1818
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016903 |
--
dsRNA
--
MO000022224
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m119368
10
infinite
0
TRANSPATH | MO000022224 |
--
dsRNA:TLR3:TRIF
--
MO000041437
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19305
10
infinite
0
TRANSPATH | MO000041437 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
MAVS
--
MO000094908
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m68199
10
infinite
0
TRANSPATH | MO000094908 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
TANK:TBK1
--
e10
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m10
0
infinite
0
--
--
e11
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m11
0
infinite
0
--
csml-variable:Double
m12
0
infinite
0
--
TLR9:CpG DNA
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
TLR9:CpGDNA:MyD88
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
TLR9:CpGDNA:MyD88:IRF-7
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
IFN-alpha
--
e16
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m16
0
infinite
0
--
TRAF6:IRAK-1:IRAK-4
--
e17
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m17
0
infinite
0
--
Imiquimod
--
e18
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
TLR7:Imiquimod
--
e19
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
MyD88:TRAF6:IRAK-1
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m20
0
infinite
0
--
TLR7:Imiquimod:MyD88:TRAF6:IRAK-1
--
e21
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m21
0
infinite
0
--
DDX58:ssRNA
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m24
0
infinite
0
--
ssRNA
--
e25
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m25
0
infinite
0
--
IFIH1:dsRNA:MAVS
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
IFIH1:dsRNA
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
DDX58:dsRNA
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
PKR
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
PKR:dsRNA
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
NF-KappaB:IKappaB
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m31
0
infinite
0
--
NF-KappaB:IKappaB{p}
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m32
0
infinite
0
--
dsRNA:TLR3{p}:PI3K:TBK1
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
c-Jun:ATF-2
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
c-Jun:ATF-2{active}
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
DDX58:dsRNA:MAVS
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
DDx58:dsRNA:MAVS:TANK:TBK1:IKK-i
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
dsRNA:TLR3:TRIF:RIP1
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
NF-kappaB{active}
--
e40
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m43
10
infinite
0
TRANSPATH | MO000000058 |
--
dsRNA:TLR3:TRIF:TANK:TBK1:IKK-i
--
e41
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
IRF-3{p}:IRF-3{P}
--
e43
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m46
0
infinite
0
--
TANK:TBK1:IKK-i
--
e45
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m48
0
infinite
0
--
IFIH1:dsRNA:MAVS:TANK:TBK1:IKK-i
--
e46
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
IFIH1:dsRNA:MAVS:IKK
--
e47
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
DDx58:dsRNA:MAVS:IKK
--
e48
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
NS3/4A
--
e49
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m65
0
infinite
0
--
--
e5
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
--
e6
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
ISG56
--
e64
cso30:c:mRNA
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m68
0
infinite
0
--
IRF-3{p}:IRF-3{p}:CBP
--
e65
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m69
0
infinite
0
--
IRF-3{p}:IRF-3{p}:CBP
--
e66
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m70
0
infinite
0
--
Wortmannin
--
e67
cso30:c:SmallMolecule
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m71
0
infinite
0
--
LY294002
--
e68
cso30:c:SmallMolecule
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m72
0
infinite
0
--
ISG56
--
e69
cso30:c:Dna
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m73
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
IRF{p}(2):CBP:ISG56
--
e70
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m74
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m12*m19828*0.1
nodelay
--
0
PMID: 17904888,14971051 TLR9 recognises dsDNA, often in the form of unmethylated CpG deoxyoligonucleotides
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m25*m41844*0.1
nodelay
--
0
PMID: 17904888,17038589 RIG-I recognises dsRNA and also is thought to associate with 50-triphosphorylated ssRNA derived from virally infected cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m76904*m119368*0.1
nodelay
--
0
PMID: 17904888,16127453 MDA5 has a helicase/CARD structure similar to that of RIG-I, and like RIG-I the helicase domain of MDA5 binds to viral dsRNA and its CARD domain can bind to the CARD-containing region of CARDIF/IPS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m27*m68199*0.1
nodelay
--
0
PMID: 17904888,16127453 MDA5 has a helicase/CARD structure similar to that of RIG-I, and like RIG-I the helicase domain of MDA5 binds to viral dsRNA and its CARD domain can bind to the CARD-containing region of CARDIF/IPS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m119368*m29*0.1
nodelay
--
0
PMID: 17904888 PKR homodimers are constitutively expressed in the cytoplasm, and activated by dsRNA ligation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c42 : 1
stoichiometry:c41 : 1
m31*m30*0.1
nodelay
--
0
PMID: 17904888,7912826 NF-kB is a target of PKR, activated through phosphorylation of the inhibitor of NF-kB, IkB [35], or activation of the kinase phosphorylating IkB, IKK-a/ b
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c44 : 1
m19314*0.1
nodelay
--
0
PMID: 17904888,15502848 An initial study by Sarkar, in HEK293 cells revealed that TLR3 phosphorylation at conserved tyrosine residues within the intracellular domain recruits both TBK1 and PI3K.
p16
p16
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m33*m34*m3902*0.1
nodelay
--
0
PMID: 17904888,15502848 An initial study by Sarkar, in HEK293 cells revealed that TLR3 phosphorylation at conserved tyrosine residues within the intracellular domain recruits both TBK1 and PI3K.
p17
p17
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c51 : 1
stoichiometry:c50 : 1
m1818*m36*0.1
nodelay
--
0
PMID: 17904888 JNK2 also activates c-Jun, half of the heterodimeric ATF-2/c-Jun transcription factor required for IFN-b expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m37*0.1
nodelay
--
0
PMID: 17904888 JNK2 also activates c-Jun, half of the heterodimeric ATF-2/c-Jun transcription factor required for IFN-b expression
p19
p19
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c130 : 1
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m68199*m75*0.1
nodelay
--
0
PMID: 17904888 The upstream activator or dsRNA recognition molecule that activates JNK2 in response to viral infection is currently unknown, however over-expression of the RIG-I adaptor CARDIF/ MAVS/VISA/IPS has been reported to activate JNK
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m13*m1572*0.1
nodelay
--
0
PMID: 17904888,12900525 The downstream signalling proteins required for TLR9 mediated IFN-a gene include the adaptor MyD88, as DCs from MyD88 knockout mice fail to produce IFN-a
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
stoichiometry:c107 : 1
stoichiometry:c56 : 1
m28*m68199*0.1
nodelay
--
0
PMID: 17904888,16127453 Subsequent biochemical analysis identified RIG-I as an RNA helicase with a self-inhibiting conformation; unwinding of viral dsRNA in the presence of ATP allows the CARD signalling domains access to a CARD containing intermediate, identified by four groups as CARDIF, VISA, MAVS and IPS-1 PMID: 17904888,16585524 NS3or4A was observed to specifically cleave the helicase adaptor IPS-1, causing a loss of RIG-I and IPS-I interaction
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c61 : 1
m38*m48*0.1
nodelay
--
0
PMID: 17904888 This complex then makes contact with a kinase complex, which includes TANK, TANK binding kinase 1 (TBK1) and IKK-i/epsilon.
p23
p23
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m3965*m119368*0.1
nodelay
--
0
PMID: 17904888,11607032 TLR3 was first identified in 2001 as an extracellular receptor for dsRNA in both human and murine cells
p24
p24
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m19314*m18998*0.1
nodelay
--
0
PMID: 17904888 Further studies identified an important adaptor protein under the control of TLR3, termed TIR domain-containing adapter inducing IFN-b (TRIF)
p25
p25
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m19305*m40*0.1
nodelay
--
0
PMID: 17904888,15064760 The dual role of TRIF in both IFN-b gene expression and NF-kB activation can be further explained by the identification of kinase receptor interacting protein (RIP)-1
p26
p26
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m41*m42*0.1
nodelay
--
0
PMID: 17904888 Hence RIP-1 mediates the NF-kB activating arm of TRIF mediated TLR3 function.
p27
p27
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c78 : 1
stoichiometry:c76 : 1
stoichiometry:c79 : 1
m19305*m1599*m10*0.1
nodelay
--
0
PMID: 17904888 TLR3 ligation can activate IRF-3 via TRIF, and involves the kinases TBK1 and IKK-i or epsilon.
p28
p28
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m44*m977*0.1
nodelay
--
0
PMID: 17904888,12692549,16127453,16177806,14703513 ,16153868 Both the TLR3 associated adapter TRIF, and RIG-I adaptor CARDIF , have been immunoprecipitated with IKK-i/epsilon or TBK1, and these kinases have been shown to directly phosphorylate IRF-3 at Ser386, leading to its dimerisation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c83 : 1
m45*0.1
nodelay
--
0
PMID: 17904888,12692549,16127453,16177806,14703513 ,16153868 Both the TLR3 associated adapter TRIF, and RIG-I adaptor CARDIF , have been immunoprecipitated with IKK-i/epsilon or TBK1, and these kinases have been shown to directly phosphorylate IRF-3 at Ser386, leading to its dimerisation PMID: 17904888 Subsequent experiments showed that TLR3 mediated signalling to IRF-3 requires both TBK1 and PI3K for full phosphorylation of IRF-3 at Ser396, possibly via the PI3K target Akt, and hence formation of IRF-3 dimers and full induction of IRF responsive genes, such as ISG56.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m14*m980*0.1
nodelay
--
0
PMID: 17904888,12900525 Further studies have demonstrated that in pDCs and HEK293 cells, TLR9 ligation causes the adaptor MyD88 to interact with the transcription factor IRF-7 and induce IFN-a gene expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
m46*0.1
nodelay
--
0
PMID: 17904888 Lung fibroblasts, and macrophages from TRIF deficient mice also had impaired IRF-3 phosphorylation after polyIC ligation suggesting TRIF induces IFN-b via the transcription factor IRF-3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
m93217*0.1
nodelay
--
0
PMID: 17904888 Lung fibroblasts, and macrophages from TRIF deficient mice also had impaired IRF-3 phosphorylation after polyIC ligation suggesting TRIF induces IFN-b via the transcription factor IRF-3.
p32
p32
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c89 : 1
stoichiometry:c90 : 1
m39*m977*0.1
nodelay
--
0
PMID: 17904888 RNA helicases RIG-I and MDA recognise intracellular viral dsRNA or ssRNA and activate NF-kB via IKK-b, or IRF-3 via TBK1, IKK-ior epsilon.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c91 : 1
m26*m48*0.1
nodelay
--
0
PMID: 17904888 This complex then makes contact with a kinase complex, which includes TANK, TANK binding kinase 1 (TBK1) and IKK-i/epsilon.
p32
p34
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m49*m977*0.1
nodelay
--
0
PMID: 17904888 RNA helicases RIG-I and MDA recognise intracellular viral dsRNA or ssRNA and activate NF-kB via IKK-b, or IRF-3 via TBK1, IKK-ior epsilon.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c95 : 1
stoichiometry:c97 : 1
m207*m26*0.1
nodelay
--
0
p32
p36
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m63*m42*0.1
nodelay
--
0
PMID: 17904888 RNA helicases RIG-I and MDA recognise intracellular viral dsRNA or ssRNA and activate NF-kB via IKK-b, or IRF-3 via TBK1, IKK-ior epsilon.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m38*m207*0.1
nodelay
--
0
p32
p38
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c106 : 1
stoichiometry:c105 : 1
m42*m64*0.1
nodelay
--
0
PMID: 17904888 RNA helicases RIG-I and MDA recognise intracellular viral dsRNA or ssRNA and activate NF-kB via IKK-b, or IRF-3 via TBK1, IKK-ior epsilon.
p39
p39
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c113 : 1
stoichiometry:c110 : 1
m977*m67*0.1
nodelay
--
0
PMID: 17904888 Subsequent experiments showed that TLR3 mediated signalling to IRF-3 requires both TBK1 and PI3K for full phosphorylation of IRF-3 at Ser396, possibly via the PI3K target Akt, and hence formation of IRF-3 dimers and full induction of IRF responsive genes, such as ISG56.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m17*m15*0.1
nodelay
--
0
PMID: 17904888,12900525 Further studies have demonstrated that in pDCs and HEK293 cells, TLR9 ligation causes the adaptor MyD88 to interact with the transcription factor IRF-7 and induce IFN-a gene expression. PMID: 17904888 This process involves a kinase complex containing TRAF6 and the IL-1 receptor associated kinase (IRAK). PMID: 17904888,15767370 In the different cell types, different family members of IRAK appear to be important, in pDCs, IRAK-1 was required however in HEK cells IRAK-4 was responsible
p40
p40
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c111 : 1
stoichiometry:c112 : 1
m35*m66*0.1
nodelay
--
0
PMID: 17904888 Subsequent experiments showed that TLR3 mediated signalling to IRF-3 requires both TBK1 and PI3K for full phosphorylation of IRF-3 at Ser396, possibly via the PI3K target Akt, and hence formation of IRF-3 dimers and full induction of IRF responsive genes, such as ISG56.
p41
p41
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c122 : 1
stoichiometry:c127 : 1
stoichiometry:c115 : 1
m74*0.1
nodelay
--
0
PMID: 17904888 Subsequent experiments showed that TLR3 mediated signalling to IRF-3 requires both TBK1 and PI3K for full phosphorylation of IRF-3 at Ser396, possibly via the PI3K target Akt, and hence formation of IRF-3 dimers and full induction of IRF responsive genes, such as ISG56. PMID: 17904888 Importantly, ISG56 expression could be inhibited by wortmannin and LY294002, potent inhibitors of PI3K, and IRF-3 association with CBP and the ISG56 promoter was inhibited, but nuclear translocation of IRF-3 was not inhibited.
p42
p42
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c116 : 1
stoichiometry:c123 : 1
stoichiometry:c124 : 1
stoichiometry:c117 : 1
m46*m2282*0.1
nodelay
--
0
PMID: 17904888 Subsequent experiments showed that TLR3 mediated signalling to IRF-3 requires both TBK1 and PI3K for full phosphorylation of IRF-3 at Ser396, possibly via the PI3K target Akt, and hence formation of IRF-3 dimers and full induction of IRF responsive genes, such as ISG56.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
m69*0.1
nodelay
--
0
PMID: 17904888 Subsequent experiments showed that TLR3 mediated signalling to IRF-3 requires both TBK1 and PI3K for full phosphorylation of IRF-3 at Ser396, possibly via the PI3K target Akt, and hence formation of IRF-3 dimers and full induction of IRF responsive genes, such as ISG56.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c125 : 1
stoichiometry:c128 : 1
stoichiometry:c129 : 1
stoichiometry:c126 : 1
m70*m73*0.1
nodelay
--
0
PMID: 17904888 Subsequent experiments showed that TLR3 mediated signalling to IRF-3 requires both TBK1 and PI3K for full phosphorylation of IRF-3 at Ser396, possibly via the PI3K target Akt, and hence formation of IRF-3 dimers and full induction of IRF responsive genes, such as ISG56.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m18*m19940*0.1
nodelay
--
0
PMID: 17904888,14530357 The TLR7 ligand imiquimod induces IFN-a in pDCs and monocytes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m19*m20*0.1
nodelay
--
0
PMID: 17904888 TLR7 ligation involves a signalling pathway consisting of MyD88, TRAF6 and IRAK-1, and this complex leads to IRF-5 and IRF-7 activation in HEK293 cells.
p7
p7
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m21*m979*0.1
nodelay
--
0
PMID: 17904888 TLR7 ligation involves a signalling pathway consisting of MyD88, TRAF6 and IRAK-1, and this complex leads to IRF-5 and IRF-7 activation in HEK293 cells.
p7
p8
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m21*m980*0.1
nodelay
--
0
PMID: 17904888 TLR7 ligation involves a signalling pathway consisting of MyD88, TRAF6 and IRAK-1, and this complex leads to IRF-5 and IRF-7 activation in HEK293 cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m119368*m41844*0.1
nodelay
--
0
PMID: 17904888,17038589 RIG-I recognises dsRNA and also is thought to associate with 50-triphosphorylated ssRNA derived from virally infected cells
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--